21229 ⎘
Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
MALARIA IMMUNOGEN AND METHODS OF USING SAME
#2NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
#3TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES
#4COMBINATION TREATMENT REGIMES FOR TREATING CANCER
#5BIODEGRADABLE POLYMERIC PARTICLES FOR DELIVERY OF POSITIVELY CHARGED THERAPEUTIC AGENTS
#6PEPTIDE AND NUCLEIC ACID METHODS TO MODULATE DELIVERY OF NUCLEIC ACID STRUCTURES, POLYPEPTIDES, AND THEIR CARGOES
#7MICELLE COMPRISING AMPHIPHILIC PEPTIDE, AND ANTIGEN CARRIER NANOPARTICLE USING SAME
#8RESPIRATORY SYNCYTIAL VIRUS SURFACE GLYCOPROTEIN PEPTIDES, CONJUGATES, AND USES THEREOF
#9GLYCOTARGETING THERAPEUTICS
#10Methods and Compositions for Treating Infections
#11COMPOSITIONS OF NUCLEIC ACID NANOSTRUCTURES FOR VACCINES AND METHODS OF USE THEREOF
#12METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#13Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
#14Compositions of Phosphorylated Tau Peptides and Uses Thereof
#15ALK POLYPEPTIDES AND METHODS OF USE THEREOF
#16COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
#17VACCINE COMPOSITION AGAINST CORONAVIRUS
#18EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY
#19GLYCOTARGETING THERAPEUTICS
#20Staphylococcal protein variants and truncates
#21VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND FELINE IL-1 BETA MUTEIN ANTIGENS
#22VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND CANINE IL-1 BETA MUTEIN ANTIGENS
#23VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND IL-1 BETA MUTEIN ANTIGENS
#24Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#25PFCSP-BASED IMMUNOGENS AND RELATED COMPOSITION AND METHODS
#26COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER
#27Immunogenic Compositions of Polysaccharide-Protein Pegylated Compounds
#28Multivalent Vaccine Compositions
#29DNA ADJUVANT HYDROGEL-BASED PEPTIDE VACCINE, AND PREPARATION METHOD AND USE THEREOF
#30ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
#31COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#32POLYMERIC VACCINE FOR OPIOID ADDICTION
#33POLYMER ADJUVANT
#34INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF
#35MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS
#36CHEMICALLY MODIFIED BACTERIAL PEPTIDOGLYCAN COMPOSITIONS AND USES THEREOF
#37ERYTHROCYTE-BINDING THERAPEUTICS
#38HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#39MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF
#40CONJUGATED VACCINE CARRIER PROTEINS
#41Therapeutic Anticancer Neoepitope Vaccine
#42Anti-Abeta Therapeutic Vaccines
#43POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDS
#44COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE
#45NANOPARTICLE COMPOSITIONS FOR SUSTAINED THERAPY
#46MULTIPLE FUNCTIONALIZED noMV CONJUGATES
#47ARTICLES COMPRISING A SILK POLYPEPTIDE FOR ANTIGEN DELIVERY
#48Phosphorylated Polypeptide Antigen Vaccine, Preparation Method Therefor and Application Thereof
#49ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS
#50NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
#51THERAPEUTIC COMBINATION FOR TREATING CANCER
#52CARRIER PROTEIN FOR PEPTIDE ANTIGEN
#53ADMINISTRATION REGIMENS FOR MICRONEEDLE PATCH DEVICES FOR DELIVERY OF IMMUNOGENIC COMPOSITIONS
#54T-Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof
#55Vaccines targeting Pseudomonas aeruginosa
#56T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
#57CARBOHYDRATE STRUCTURES AND USES THEREOF
#58Modified biotin-binding protein, fusion proteins thereof and applications
#59EXOSOMES FOR IMMUNO-ONCOLOGY AND ANTI-INFLAMMATORY THERAPY
#60METHOD OF GENERATING VACCINES
#61COMPOSITIONS AND METHODS FOR ENHANCING T CELL PENETRATION OF TUMORS AND CANCERS
#62Structure-Function Relationships in the Development of Immunotherapeutic Agents
#63Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#64GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
#65APC targeting units for immunotherapy
#66MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#67MODIFIED MYCOBACTERIUM BOVIS VACCINES
#68ALK POLYPEPTIDES AND METHODS OF USE THEREOF
#69LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#70Heterologous Administration of Tau Vaccines
#71INDIVIDUALIZED VACCINES FOR CANCER
#72VACCINES FORMED BY VIRUS AND ANTIGEN CONJUGATION
#73IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6
#74Immunogenic compositions of polysaccharide-protein pegylated compounds
#75IMMUNOGENIC PEPTIDES WITH AN OXIDOREDUCTASE MOTIF COMPRISING A MODIFIED CYSTEINE
#76STABILIZATION OF MHC COMPLEXES
#77GLYCOTARGETING THERAPEUTICS
#78Conjugate Vaccines Containing Hydrazine-PEG-Hydrazine Linkers
#79CD38 modulating antibody
#80Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#81VIRUS-LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY
#82COMPOUNDS FOR THE INDUCTION OF ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#83Virus-Like Particle Vaccines for Opioid Drugs
#84Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#85CELL SURFACE ANCHORING ANTIGEN CONJUGATES TO TREAT CANCER
#86NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
#87POLYMERIC NANOPARTICLES THAT TARGET LIVER SINUSOIDAL ENDOTHELIAL CELLS TO INDUCE ANTIGEN-SPECIFIC IMMUNE TOLERANCE
#88IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF
#89Therapeutic anticancer neoepitope vaccine
#90MODIFIED VIRUS-LIKE PARTICLES OF CMV
#91STABILIZED CHIMERIC SYNTHETIC PROTEINS AND THERAPEUTIC USES THEREOF
#92CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY BINDING TO CD 300C ANTIGEN OR RECEPTOR THEREOF
#93Circumsporozoite proteins with increased expression in mammalian cells
#94BRUSH POLYMERS FOR THERAPEUTIC APPLICATIONS
#95Vaccine Adjuvants for Antigen Delivery
#96Methods and compositions for treating infections
#97Covalently modified antigens for improved immune response and/or stability
#98COMPOSITIONS AND METHODS FOR INDUCING IMMUNE TOLERANCE
#99Therapeutics for autoimmune disease: synthetic antigens
#100compositions and methods thereof
#101CANCER VACCINE FORMULATION
#102ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS
#103IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
#104PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION
#105Glycoconjugation processes and compositions
#106O-LINKED GLYCOSYLATION RECOGNITION MOTIFS
#1076-acetylmorphine analogs, and methods for their synthesis and use
#108Multi-functionalized nOMV conjugates
#109Heat Shock Protein-Binding Peptide Compositions And Methods Of Use Thereof
#110BI-SPECIFIC CONJUGATES
#111IMMUNOGENIC PEPTIDES WITH IMPROVED OXIDOREDUCTASE MOTIFS
#112Compositions of Phosphorylated Tau Peptides and Uses Thereof
#113CD40 AND CD40L COMBO IN AN ADV VACCINE VEHICLE
#114Articles comprising a silk polypeptide for antigen delivery
#115Nano-satellite complexes
#116Articles comprising a silk polypeptide for antigen delivery
#117Multiple antigen presenting immunogenic composition, and methods and uses thereof
#118Fusion proteins comprising an anti-CD40 antibody and cancer antigens
#119Antibodies Targeted to Fungal Cell Wall Polysaccharides
#120Anti-parasitic immunological compositions
#121Compositions and methods for preventing tumors and cancer
#122Vaccines formed by virus and antigen conjugation
#123Combined formulation comprising four linked cytotoxic T lymphocyte (CTL) epitopes and a PD-1 pathway inhibitor and methods of use thereof to treat cancer
#124Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same
#125METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS AND RELATED DISORDERS
#126Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
#127Dendritic gold nanoparticles and methods of synthesis
#128Immunostimulatory compositions, particles, and uses related thereto
#129COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#130Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#131IMPROVED METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES
#132Mixtures of polysaccharide protein pegylated compounds
#133Methods and compositions for substance use disorder vaccine formulations and uses thereof
#134Anti-abeta therapeutic vaccines
#135Neoglycoconjugates as vaccines and therapeutic tools
#136Erythrocyte-binding therapeutics
#137COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF IMMUNE COMPLEX DISEASE
#138Small molecule Ras inhibitors
#139POLYMER ADJUVANT
#140HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
#141Exosomes for immuno-oncology and anti-inflammatory therapy
#142Modified biotin-binding protein, fusion proteins thereof and applications
#143ALK polypeptides and methods of use thereof
#144NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE
#145Structure-Function Relationships in the Development of Immunotherapeutic Agents
#146Compositions of phosphorylated tau peptides and uses thereof
#147CD38 modulating antibody
#148Compositions and uses
#149Antibodies targeted to fungal cell wall polysaccharides
#150Heterologous administration of tau vaccines
#151Methods and compositions for treating and preventing HIV
#152AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS
#153PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS
#154Method of safe administration of phosphorylated tau peptide vaccine
#155Immunogenic glycoprotein conjugates
#156Glycoconjugation processes and compositions
#157Compounds and therapeutics uses thereof
#158Silvestrol antibody-drug conjugates and methods of use
#159Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#160Glycoconjugate vaccines, preparation method and uses thereof
#161CONJUGATE VACCINE USING TRIMMING FUNCTION OF ERAP1
#162Covalently linked antigen-antibody conjugates
#163Modified virus-like particles of CMV
#164Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, bacillus anthracis and yersinia pestis
#165Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#166Glycotargeting therapeutics
#167Glycotargeting therapeutics
#168Virus-like particle with efficient epitope display
#169METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF
#170Methods and compositions for treating and preventing HIV
#171Compositions and methods for inducing immune tolerance
#172NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF
#173Antibodies targeted to fungal cell wall polysaccharides
#174compositions and methods thereof
#175PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#176Conjugated vaccine carrier proteins
#177Mixtures of polysaccharide-protein pegylated compounds
#178Synthetic vaccines against serotype 2
#179Methods and compositions for treating multiple sclerosis and related disorders
#180IMMUNOGENIC COMPOSITION
#181Heat shock protein-binding peptide compositions and methods of use thereof
#182Methods for improving immunological response in vaccinated animals
#183Carbohydrate structures and uses thereof
#184Vaccines targeting
#185Immunogenic composition for MERS coronavirus infection
#186IMMUNOMODULATORY COMPOSITIONS, PROCESSES FOR MAKING THE SAME, AND METHODS FOR INHIBITING CYTOKINE STORMS
#187Anti-abeta therapeutic vaccines
#188Immunogenic composition
#189Precision glycoconjugates as therapeutic tools
#190Re-directed immunotherapy
#191Vaccine
#192Exosomes for immuno-oncology and anti-inflammatory therapy
#193HER-1, HER-3 and IGF-1R compositions and uses thereof
#194Methods and compositions for treating and preventing HIV
#195Antibodies targeted to fungal cell wall polysaccharides
#196Articles comprising a silk polypeptide for antigen delivery
#197Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration
#198Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same
#199Compositions of phosphorylated tau peptides and uses thereof
#200Modified biotin-binding protein, fusion proteins thereof and applications
#201Method for vaccination against a self-antigen in a human patient
#202Individualized vaccines for cancer
#203Nanoparticle compositions for sustained therapy
#204THERAPEUTIC ANTICANCER NEOEPITOPE VACCINE
#205Bordetella pertussis immunogenic vaccine compositions
#206Virus-like particle with efficient epitope display
#2076-ACETYLMORPHINE ANALOGS, AND METHODS FOR THEIR SYNTHESIS AND USE
#208Manufacture of vaccines and compositions for the prevention of infections
#209Vaccines and compositions for the prevention of infections
#210Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#211Reversible protein multimers, methods for their production and use
#212Methods for the prevention of infections
#213Polypeptide-antigen conjugates with non-natural amino acids
#214Method for prevention or treatment of one or more of diseases relevant to the protein in the protein-cell conjugate, malignant tumors, infectious diseases caused by pathogenic microorganisms and autoimmune diseases
#215Cell surface anchoring antigen conjugates to treat cancer
#216Immunogenic compositions and reagents for preparing
#217Methods and compositions for liposomal formulation of antigens and uses thereof
#218Polymer conjugate vaccines
#219Dual anthrax-plague vaccines that can protect against two tier-1 bioterror pathogens, and
#220Methods and compounds for eliminating immune responses to therapeutic agents
#221IMMUNOMODULATORY AGENT-POLYMERIC COMPOUNDS
#222Antibodies targeted to fungal cell wall polysaccharides
#223VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
#224Injectable vaccines against multiple meningococcal serogroups
#225Coiled-coil connector
#226Glycoconjugation processes and compositions
#227Pneumococcal capsular saccharide conjugate vaccine
#228Method of inducing an immune response against human immunodeficiency virus comprising administering immunogenic compositions comprising authentic trimeric HIV-1 envelope glycoproteins containing a long linker and tag
#229VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES
#230Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment
#231Conjugation of type 5 and type 8 capsular polysaccharides
#232Virus-like particle with efficient epitope display
#233Drug conjugates comprising antibodies against claudin 18.2
#234Immunostimulatory compositions, particles, and uses related thereto
#235Erythrocyte-binding therapeutics
#236Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides
#237Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#238Immunogenic composition
#239Method of developing a vaccine using peptide-poly IC complexes
#240Compositions and uses
#241IMMUNOGENIC COMPOSITIONS
#242Immunogenic/therapeutic glycan compositions and uses thereof
#243Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
#244Silvestrol antibody-drug conjugates and methods of use
#245Vaccines against serotype 4
#246COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#247Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
#248Modified virus-like particles of CMV
#249Methods and compositions for treating multiple sclerosis and related disorders
#250VACCINE COMPOSITIONS AND METHODS OF USE TO TREAT NEONATAL SUBJECTS
#251Small molecule Ras inhibitors
#2526-acetylmorphine analogs, and methods for their synthesis and use
#253Compositions comprising CH505 envelopes, and trimers
#254Conjugation of capsular saccharides
#255NOVEL COCAINE HAPTENS AND NANOFIBER-BASED COCAINE VACCINES
#256Vaccines against serotype 8
#257Glycoconjugation processes and compositions
#258SYNERGISTIC TUMOR TREATMENT WITH IL-2, A THERAPEUTIC ANTIBODY, AND A CANCER VACCINE
#259Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#260RECOMBINANT T CELL RECEPTOR LIGAND COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CANCER
#261PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
#262Methods and compositions for liposomal formulation of antigens and uses thereof
#263Compositions and methods for rendering tumor cells susceptible to CD8+ T cell-mediated killing
#264Amino acid and peptide conjugates and conjugation process
#265Nanoparticle compositions for sustained therapy
#266Crosslinked vaccination composition
#267Xenoantigen-displaying anti-cancer vaccines and method of making
#268Immunogenic composition
#269Peptide vaccines against PCSK9
#270Composition comprising branched multipeptide vaccine and vaccine comprising the same
#271Bifunctional conjugate compositions and associated methods
#272Injectable vaccines against multiple meningococcal serogroups
#273CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE
#274Synthetic vaccines against type 1
#275IMMUNOGENIC/THERAPEUTIC GLYCOCONJUGATE COMPOSITIONS AND USES THEREOF
#276immunogenic vaccine compositions
#277Approach to produce HIV-1 GP140 envelope protein trimers
#278Approach to produce HIV-1 GP140 envelope protein trimers
#279Method of purifying authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#280Authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag
#281Authentic trimeric HIV-1 envelope glycoproteins comprising a long linker and tag
#282COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS
#283Salmonella conjugate vaccines
#284Polyvalent conjugate vaccine for cancer
#285Glycotargeting therapeutics
#286Vaccine comprising capsular polysaccharide conjugates
#287Protein-cell conjugate, preparation method and use thereof
#288Glycan conjugates and methods of use thereof
#289Recombinant polypeptide construct comprising multiple enterotoxigenic fimbrial subunits
#290RM2 antigens and use thereof
#291MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES
#292Glycan conjugates and use thereof
#293Stabilized HIV-1 peptide constructs comprising the gp120 C5 domain and gp41 hydrophilic domain
#294Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
#295Polysaccharide-protein conjugate vaccines
#296Gastrin peptide immunogenic composition
#297Re-directed immunotherapy
#298NONLINEAR SACCHARIDE CONJUGATES
#299Modified biotin-binding protein, fusion proteins thereof and applications
#300Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus